Clinical trial
Noninvasive Temporal Interference Stimulation for the Treatment of Drug Resistant Epilepsy
NCT06708143 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Temporal Interference Stimulation for the Treatment of Drug Resistant Epilepsy
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 30, 2024
- Completion date
- November 30, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.